Bcr-Abl

Catalog No.Inhibitor Name Bcr-AblAblOther
A10290Dasatinib
****
****
Src,c-Kit (D816V),c-Kit (wt)
A10468Imatinib Mesylate
*
c-Kit,PDGFR
A10108Saracatinib
**
c-Src,LCK,EGFR (L861Q)
A10080Ponatinib
****
****
PDGFRα,VEGFR2,FGFR1
A10644Nilotinib
**
A10715Danusertib
**
**
Aurora A,TrkA,RET
A10095AT9283
***
JAK3,JAK2,Aurora B
A10988Degrasyn
*
DUB
A10119Bafetinib
***
***
Lyn
A10508KW-2449
**
***
FLT3 (D835Y),FLT3,FGFR1
A10661NVP-BHG712
*
EphB4,C-Raf,c-Src
A11200Rebastinib
***
FLT3,KDR,Tie-2
A15849GZD824 Dimesylate
****
****
A11439GNF-2
*
A15887GNF-7
***
*
A13029Radotinib
**
A16320Dasatinib Monohydrate
****
****
Src,c-Kit (D816V),c-Kit (wt)
A13237GNF-5
*
A13120PD173955
***
Src
A11379DPH
A13530Flumatinib mesylate
****
PDGFRβ, c-Kit

Notes:
1.Hover mouse over " * " to view the IC50 value.(A few compounds have proven potency but without published IC50 data.)
2.For more details about the compound, click on the product name of your interest.
3.The higher the number of " * " is, the more potent the inhibitor or activator is.
4."" refers to compounds which do inhibitory effects on the related isoform, but without specific value.

1 Item(s)

per page

Set Descending Direction
  1. AP24534 (Ponatinib)

    Catalog No. A10080
    Quick View
    BCR-ABL inhibitor
    AP24534 (Ponatinib) is a potent multi-kinase and pan-BCR-ABL inhibitor. Learn More

1 Item(s)

per page

Set Descending Direction
Rewards